Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the score on urinary function (International Prostate Score Symptom) at 28 days. The main objective is to assess the efficacy of treatment with Ialuril® Prefill on functional recovery at 4 weeks, based on the International Prostate Score Symptom. A paired test will be performed to compare the International Prostate Score Symptom score between 0 and 28 days.


Clinical Trial Description

This is an interventional, non-comparative, open-label, monocentric study aimed at evaluating treatment with hyaluronic acid in patients who have undergone surgery (HOLEP procedure) for prostatic adenoma. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05687019
Study type Interventional
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact Christophe TOLLON, MD
Phone 561549696
Email tol@club-internet.fr
Status Recruiting
Phase N/A
Start date September 12, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02940977 - Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
Withdrawn NCT05157724 - Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
Completed NCT04693507 - Teverelix Evaluated in Advanced Prostate Cancer Phase 2
Completed NCT02943070 - Rezum I Pilot Study for Benign Prostatic Hyperplasia N/A
Completed NCT02940392 - Rezum FIM Optimization Study N/A